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Abstract:  Problem  statement:  Cellular  drug  resistance  to  anticancer  agents  is  major  obstacle  in 
cancer  chemotherapy  and  the  mechanisms  by  which  these  MDR  cells  possess  for  protecting 
themselves to survive prolonged exposure to cytotoxic agents still debating. The study aimed to clarify 
the role of P-glycoprotein (Pgp) and enhanced drug sequestration in lysosomes to confer the multidrug 
resistance K562 cells with varied degree of Pgp expression. Approach: Erythromyelogenous leukemic 
K562 and its corresponding Pgp-over expression K562/adr (RF= 26.5) and K562/10000 (RF = 39.6) 
cells  were  used.  The  transport  of  intrinsic  fluorescence  molecules  including  acridine  orange  and 
pirarubicin across plasma membrane of living cells was performed by using spectrofluorometric and 
flow cytometric analysis. Results: Pirarubicin passively diffused through the plasma membrane of 
K562, K562/adr and K562/10000 cells with the same values of k+ = 3.4±0.3 pL. s
-1.cell
-1. Similar 
results were found for acridine orange, which passively diffused through plasma membrane of these 
cell lines about 30-fold faster than pirarubicin. The mean rate of Pgp-mediated efflux coefficient (ka) of 
pirarubicin    was    equal  to  2.6  ±  0.9  pL.s
-1.cell
-1  for  K562/adr  and  4.7  ±  1.0  pL.s
-1.cell
-1  for 
K562/10000 cells. The Pgp-mediated efflux of acridine orange could not be determined for K562/adr 
cells while an enhancement of exocytosis in K562/10000 cells was characterized. The acridine orange 
exhibited antiproliferative activity and IC50 for K562, K562/adr and K562/10000 cells was 447±40, 
715±19 and 1,719±258 nM, respectively. Cytotoxicity of acridine orange was increased by 2-fold in 
the presence of and 25 nM monensin.  Conclusion: The results clearly demonstrated for the first time 
that  by  using  the  same  methods  and  cell  lines.  The  predominant  cellular  defense  mechanism 
determined  in  multidrug  resistant  cells  depends  upon  the  nature  of  molecular  probes  used.  As 
molecular probe, pirarubicin clearly showed that the Pgp-mediated efflux of drug play as predominant 
mechanism while AO clearly demonstrated the role of drug sequestration in lysosomes following an 
enhance exocytosis in both MDR sublines. 
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INTRODUCTION 
 
  Multidrug  Resistance  (MDR)  of  tumor  cells  to 
anticancer agents remains a major cause of failure in 
cancer  therapy.  MDR  is  frequently  associated  with  a 
decreased  intracellular  accumulation  of  anticancer 
drugs  due  to  an  overexpression  of  MDR  protein 
transporters  including  P-glycoprotein  (Pgp)
[1],  MRP
[2] 
and  lung  resistance  related  protein
[3].  In  fact  MDR 
phenomenon is always multifactorial. The biochemical 
and  physiological  changes  other  than  an  over-
expression of MDR protein transporters especially an 
altered  pH  gradient  across  different  cellular 
compartments  in  particular  for  acidic  organelles  of 
MDR cells was reported
[4,5]. Studies have shown that 
the  lysosomes  entrapped  following  an  enhance 
exocytosis of weak base anticancer drugs was proposed 
as  a  factor  that  favors  a  reduced  their  intracellular 
accumulation  thus  their  efficiency
[6].  Despite  many 
studies  over  recent  years,  the  role  of  MDR  protein Am. J. Applied Sci., 6 (9): 1637-1646, 2009 
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transporters  and  the  sequestration  in  acidic  vesicles 
following an enhance exocytosis of drugs on conveying 
drug resistance phenomenon were never studied in the 
same MDR cell lines. Especially for the MDR cells that 
have different degrees of drug resistance by using the 
same methods of MDR cell selection.  
  Recently  we  selected  MDR  cells  with  Pgp  over-
expression by exposing the K562/adr to a repetition of 
fixed    adriamycin    concentrations    (100,    300    and 
10000 nM) in a culture medium. We reported that (i) 
the MDR1 mRNA levels and the resistance factor (RF) 
increased  with  increase  in  the  concentration  of 
adriamycin  used  for  MDR  cell  selection  and  (ii)  the 
efficiency of Pgp-mediated efflux was proportional to 
the RF and the MDR1 mRNA levels
[7].  
  In this study, we used the same K562/adr (RF = 14) 
and  K562/10000  (RF  =  33)  cell  lines  as  models  for 
investigating the kinetics of uptake, kinetics of active 
efflux  and  drug  sequestration  in  lysosomes  by  using 
Acridine Orange (AO), in comparison with pirarubicin. 
AO is an intrinsic fluorescent molecule and is known as 
a lysosomotropic agent. It is frequently used to examine 
the  luminal  pH  of  intracellular  acidic  organelles 
(notably lysosome)
[8-11]. Because AO is a poor substrate 
of Pgp but efficiently entrapped in lysosomes, therefore 
it is a suitable probe use for investigating the role of 
drug  sequestration  in  lysosomes.  Contrary  to  AO, 
pirarubicin is a good substrate of Pgp and is used as 
molecular  probe  for  measuring  the  efficiency  of  Pgp 
mediated-efflux of drugs out of MDR cells.  
 
MATERIALS AND METHODS 
 
Drugs  and  chemicals:  Adriamycin  and  pirarubicin 
were kindly provided by Prof. Arlette Garnier-Suillerot, 
Laboratoire  de  Physicochimie  Biomoleculaire  et 
Cellulaire, UPRES A 7034 CNRS, UFR Santé Medicines 
et Biologie Humaine, Bobigny, University de Paris Nord. 
Tetrazolium  salt  (3-(4,  5-dimethyl-2thiazolyl)-2,  5-
diphenyl-2H-tetrazolium  bromide  (MTT))  was  from 
Amresco. Monensin was from Sigma.  
  Adriamycin and pirarubicin stock solutions were 
prepared in double-distilled water, just before using. 
Concentrations  were  spectrophotometrically 
determined  by  diluting  stock  solutions  in  water  to 
approximately 10 mM and using e480 = 11, 500 M
-1 cm
-1. 
A  stock solution of MTT was prepared by dissolving 
5 mg MTT mL
-1 in HEPES-Na
+ buffer and filtering 
through a 0.22 mm filter and stored at 4°C.  
  All experiments were performed using HEPES-Na
+ 
buffer which consisting of 20 mM HEPES buffer plus 
132 mM NaCl, 3.5 mM KCl, 1 mM CaCl2 and 1.5 mM 
MgCl2, pH 7.25 at 37°C.  
Cell  culture  and  cytotoxicity  assay:  The  human 
erythromyelogenous leukemic, K562 and its Pgp-over 
expression  K562/adr
[12,13]  were  routinely  cultured  in 
RPMI 1640 medium supplemented with 10% fetal calf 
serum (Gibco Biocult Ltd.). For assays, a culture was 
initiated  at  5´10
5  cells  per  mL  to  have  cells  in  the 
exponential growth phase; the cells were used 24 h later 
for  all  series  of  experiments,  when  the  culture  had 
grown  to  approximately  8´10
5  cells  per  mL.  Cell 
viability  was  assessed  by  trypan  blue  exclusion.  The 
number of cells was determined by haemocytometer. 
  The cytotoxicity assay was performed as follows: 
5´10
4 cells per mL were incubated in the presence of 
various THP concentrations. The viability of cells was 
determined  by  MTT-reduction.  The  IC50  (conc.  of 
compound  that  inhibited  cell  growth  by  50%,  when 
measured  at  72  h)  was  determined  by  plotting  the 
percentage  of  cell  growth  inhibition  versus  the 
concentration  of  compound.  A  Resistance  Factor  (RF) 
was defined as the IC50 of resistant cells divided by the 
IC50  of  sensitive  cells.  The  RF  of  K562/adr  and 
K562/10000 cells was equal to 26.5 and 39.6, respectively. 
 
Selection  of  MDR  cells:  Adriamycin-resistant 
K562/10000 subline was selected and characterized as 
previously  described
[6].  Briefly,  K562/adr  cells  were 
continuously  exposed  to  10  mM  adriamycin  in  the 
culture medium for three-times with the interval time of 
72 h. The MDR cells were maintained in a fresh RPMI 
1640 medium  without doxorubicin  for three passages 
before using.  
 
Theoretical approach for intracellular pH (pHi) and 
luminal pH (pHv) of lysosome determination: AO is 
a  basic  molecule  (pKa  (-NH
+
3/-NH2)  =  9.4).  In  an 
aqueous  solution  at  a  given  pH,  it  equilibrates  in 
positive  charge  (DH
+)  and  neutral  (D°)  forms  as 
indicated in reaction: 
 
DH
+ ⇋ D°+H+ 
 
  In the presence of cells, only D˚ passively diffuses 
through  plasma  membrane  into  cytoplasm  and 
intracellular organelles. In a steady state, the D° form 
equilibrates  between  the  extracellular  (D°e), 
intracellular (D°i) and lysosomal (D˚v) compartments: 
D°e Û D°I Û D°v. In fact, the dissociated constant is the 
same  in  each  compartment,  can  be  written  as  the 
following expression: 
 
( ) ( )
0 0
e e i i
a
i e
D H D H
K
DH DH
+ +
+ +
                = =
       
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  The pHi can be determined using the Eq. 1: 
 
e
e i
i
DH
pH pH pH log
DH
+
+
    - = D = -
   
  (1) 
 
where, [H
+]i and [H
+]e are the concentrations of protons 
and  [DH
+]i  and  [DH
+]e  are  the  concentrations  of 
positively  charged  forms  of  AO  in  intracellular  and 
extracellular compartments, respectively. 
  In a solution at pH 7.25, which is the value of the 
intracellular of most cells, AO is found in 1% of neutral 
and  99%  of  positive  charged  forms.  The  total 
concentration of AO is the concentration of neutral and 
charged forms found in cytoplasm (Ci) and extracellular 
(Ce) compartment and can be written as follows: 
 
0
i i i i C DH D DH
+ + = + @   (2) 
 
0
e e e e C DH D DH
+ + = + @   (3) 
 
  In the first approximation, we replaced [DH
+]i and 
[DH
+]e with Ci and Ce, respectively, in Eq. (1) which 
becomes: 
 
i
e
C
pH log
C
    D =
   
  (4) 
 
  In our experiments, the pHe is equal to 7.25 then 
pHi can be determined: 
 
i
i
e
C
pH 7.25 log
C
    = -
   
  (5) 
 
  The  lysosomal  concentration  of  AO  (Cv)  can  be 
experimentally  determined  and  the  pHv  can  be 
determined  in a similar manner as pHi, as written in 
Eq. 6: 
 
v
v i
i
C
pH pH log
C
    = -
   
  (6) 
 
Subcellular distribution of acridine orange: In order 
to determine the kinetics of uptake and Pgp-mediated 
efflux,  overall  cellular  and  lysosomal  AO 
concentrations,  a  continuous  dialysis  device  was 
coupled with the spectrofluorometer (Perkin-Elmer LS 
55) was applied in the experiments. The experiments 
were  conducted  in  a  1  cm  optical  quartz  cuvette 
containing 3.5 mL of buffer solution with 0.2 mm pore 
diameter membrane dialysis compartment (a container 
of cells) placed on the top and was continuously stirred 
at 37°C. The excitation beam was passed through the 
bottom part of the cuvette, which means only AO in 
supernatant was excited. The fluorescence intensity of 
AO at 527 nm (excited at 491 nm) was measured as a 
function of time. After addition of AO into the system, 
the AO fluorescence intensity immediately increased to 
be  F0  following  a  decrease  then  stable.  This  due  to 
amounts of AO was adsorbed on to the surface of the 
dialysis compartment. The steady state was reached in 
30  min  and  the  fluorescence  intensity  became  FT. 
Where the FT was proportional to the AO concentration 
added up to 5 mM. 
  The  CT  corresponds  to  the  quantities  of  AO 
available for the experiment and can be determined as 
follows: 
 
0 0
T T
T
F
C C
F
 
= ´ 
 
  (7) 
 
where,  C
0
T  and  F0  are  the  known  final  AO 
concentration  added  into  a  cuvette  and  its 
corresponding fluorescence intensity, respectively.  
  It was confirmed that the AO fluorescence spectral 
shape and intensity did not change in the supernatant of 
cells.  Cells  (10
6  cell.mL
-1)  were  introduced  into  the 
dialysis  compartment;  a  decrease  in  AO  fluorescence 
intensity  was  due  to  the  extracellular  drug,  which 
passed  through  the  dialysis  membrane  and  was 
incorporated by cells. A new steady state was attained 
at  60  min,  where  AO  fluorescence  intensity  was 
identified as Fc, after which 3 mM monensin was added 
for  eliminating  any  intracellular  pH  gradient  (DpH) 
formation, resulting in an increase in AO fluorescence 
intensity  to  be  Fmon.  Thereafter,  0.02%  (v/v)  saponin 
was successively added, resulting in total permeability 
of the plasma membrane, leading the system to reach 
the  equilibrium  state.  At  steady  state,  the  free 
extracellular  (Ce)  and  lysosomal  (Cv)  AO 
concentrations can be calculated from Eq. 8 and 9:  
 
c
e T
T
F
C C
F
 
= ´ 
 
  (8) 
 
( ) mon c
v T
T
F F
C C
F
  -   = ´ 
   
  (9) 
 
where,  Fmon  is  AO  fluorescence  intensity  at  a  steady 
state after the addition of 3 mM monensin.  Am. J. Applied Sci., 6 (9): 1637-1646, 2009 
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  In  the  presence  of  3  mM  monensin,  any 
intracellular pH gradient (DpH) formation, in particular 
lysosomes,  was  eliminated.  A  new  steady  state  was 
reached, where AO equilibrated between extracellular 
and cytoplasm compartments. 
  The  extracellular  (CE)  and  cytoplasm  (CI)  AO 
concentrations can be determined using Eq. 10 and 11: 
 
( ) T mon
I T
T
F F
C C
F
  -   = ´ 
   
  (10) 
 
mon
E T
T
F
C C
F
 
= ´ 
 
  (11) 
 
  The intracellular  AO concentration (Ci) at steady 
state, after addition of cells can be determined: 
 
I
i e
E
C
C C
C
 
= ´ 
 
  (12) 
 
  The initial rate of uptake (Vi
+)t=0 (passive influx) 
was determined from the equation: 
 
T
i
T t cell
dF C
V .
dt F
+
=
   
=    
   
 
 
where, 
t cell
dF
dt =
 
 
 
  is  the  slope  (in  absolute  value)  of 
tangent to the curve F = f(t). The rate of Pgp-mediated 
efflux (Va)s of AO was determined as followed
[12]: 
 
( ) ( ) a e i S V k n C C + = ´ ´ -   (13) 
 
Cellular  uptake  and  the  Pgp-mediated  efflux  of 
pirarubicin:  The  rationale  and  validation  of 
experimental setup for measuring the kinetics of uptake 
and Pgp-mediated efflux of pirarubicin in the cells had 
been  largely  described
[7,12,13].  Briefly,  in  a  typical 
experiment,  conducted  in  a  1  cm  quartz  cuvette 
containing  2  mL  of  HEPES-Na
+  buffer,  2×10
6  cells 
were incubated for 30 min in the presence of 10 mM of 
sodium  azide  and  in  the  absence  of  glucose,  under 
continuous  stirring  at  pH  7.25  and  37°C.  The 
concentration  of  pirarubicin  added  to  the  cell 
suspension  was  varied  from  0.5
-10  mM.  The 
fluorescence  intensity  of  pirarubicin  at  590  nm 
(excitation at 480 nm) was recorded as a function of 
time (model LS 55 spectrofluorometer, Perkin-Elmer). 
The drug influx was measured by the decrease of the 
fluorescence intensity that occurred during incubation 
with cells due to the quenching of the fluorescence after 
pirarubicin intercalated between the base pairs of DNA 
in  nuclei  or  accumulated  into  acidic  intracellular 
organelles.  This  methodology  allowed  us  to  measure 
accurately  the  free  cytosolic  concentration  of 
pirarubicin  in  a  steady  state  (Ci),  its  initial  rate  of 
uptake (V
+
i) and the rate of Pgp-mediated efflux (Va). 
At the end of the experiment, intactness of cells was 
confirmed by trypan blue exclusion. 
 
Flow  cytofluorometric  analysis:  The  cellular 
distribution  of  AO  was  characterized  by  using  both 
fluorescence  microscope  and  flow  cytometer.  For  the 
assays, 2×10
6 cells were suspended in 2 mL HEPES-
Na
+ buffer pH 7.25 at 37°C in the presence of various 
AO concentrations for 30 min, prior to: (i) Placement 
on  the  sample  holder  of  inverted  fluorescence 
microscope (Nikon model TE-2000E, using a filter box 
model  B-2E/C  coupled  with  Nikon,  digital  camera 
model  DXM  1200F)  and  (ii)  Inject  into  a  flow 
cytometer (Coulter Epics XL-MCL). 
 
Statistic  analysis:  The    results    were  presented  as 
means  ±  SD.  The  statistical
  comparisons  were 
performed using One-way ANOVA analysis, a value of 
p<0.05 was considered
 statistically significant. 
 
RESULTS 
 
Cytotoxic  effects  of  AO  and  pirarubicin:  Figure  1 
shows  the  efficacy  of  AO  and  pirarubicin  alone  to 
inhibit  cancer  growth.  Pirarubicin  potently  exhibited 
anticancer activity (IC50 = 12.5±0.7 nM) against drug-
sensitive  K562  cells  and  was  36-fold  more  effective 
than AO. Both drugs were less cytotoxic against drug-
resistant sublines; the IC50 of the pirarubicin and AO 
for K562/adr was 175±35 nM and 715±19 nM and for 
K562/10000  cells  410±85  nM  and  1,719±258  nM, 
respectively.  Figure  1  also  shows  the  efficacy  of  co-
treatment  using  pirarubicin  or  AO  with  25  nM 
monensin. It should be noted that 25 nM monensin did 
not  affect  the  viability  of  the  cells.  Results  in  the 
presence of 25 nM monensin clearly showed that the 
IC50 of AO significantly decreased in both drug-sensitive 
and drug-resistant sublines with p<0.05 (Fig. 1a), while 
no  significantly  affected  in  the  series  of  experiments 
using  pirarubicin  (Fig.  1b)  in  K562  (p  =  0.051), 
K562/10000 (p = 0.48) and K562/adr (p = 1) cells.  Am. J. Applied Sci., 6 (9): 1637-1646, 2009 
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Determination  of  the  lysosomal  concentration  (Cv) 
and  mean  influx  coefficient  (k+)  of  AO:  The 
interaction of AO with different intracellular organelles 
exhibited  the  particular  light  emission  spectra  which 
could be detected by  flow cytometer  such as (i) The 
bright  green  fluorescence  (FL2)  when  AO  bound  to 
cytoskeleton  protein,  (ii)  Dim  red  fluorescence  (FL3) 
when AO accumulated in nucleus and (iii) Bright red 
fluorescence  (FL4)  when  AO  accumulated  in 
lysosomes.  Figure  2  shows  the  mean  fluorescence 
intensity of AO bound cells; the mean red florescence 
intensity decreased (Fig. 2a, c and e) while that of the 
green fluorescence intensity increased (Fig. 2b, d and f) 
in the presence of 3 mM monensin. These indicated that 
AO was liberated from lysosomes to the cytoplasm and 
consequently  equilibrated  between  extra  and 
intracellular compartments. 
  The  quantitative  measurement  of  lysosomal  AO 
concentration (Cv) was carried out using a continuous 
dialysis  device,  coupled  with  the  spectrofluorometer. 
Figure  3  shows  typical  kinetics  of  uptake  of  AO  by 
K562 cells. The AO fluorescence intensity decayed as a 
function  of  time and reached a steady state at 100 min. 
 
  (a)  (b) 
 
Fig. 1:  Drug response pattern of MDR cell lines. Drug 
concentration required to inhibit cell growth by 
50%  (IC50)  of  (a):  Acridine  orange  alone  (□) 
and in combination with 25 nM monensin ( ); 
(b):  Pirarubicin  alone  (□)  and  in  combination 
with 25 nM monensin ( ). Data were mean ± SD, 
n = 3. *Significantly different from co-treatment 
using  pirarubicin  or  AO  and  monensin  with 
pirarubicin or AO alone by one-way ANOVA  
 
 
  (a)  (b)  (c) 
 
 
  (d)  (e)  (f) 
 
Fig. 2: Typical histograms of cell-AO bound fluorescence: Effects of 3 mM monensin on (a and b): K562, (c and d): 
K562/adr cells (e,f) K562/10000. Cells (2´10
6) were incubated with 1 mM in 2 mL of HEPES-Na
+ at 37°C 
for 30 min. The cell-bound AO fluorescence intensity was recorded by flow cytometer without or after 
immediately added 3 mM monensin. Each histogram was obtained from 10,000 cells  Am. J. Applied Sci., 6 (9): 1637-1646, 2009 
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Fig. 3: Quantitative  measurement  of lysosomal Acridine Orange (AO) concentration  [Fluorescence intensity at 
527 nm (excited at 491 nm) was registered as a function of time. AO (1 mM) was added into the cuvette 
containing 3.5 mL of HEPES-Na
+ buffer at 37°C and vigorously stirred. At steady state, 3.5´10
6 cells were 
added, yielding a progressive decrease in fluorescence intensity then reached a new steady state and after 
that indicated monensin concentration was added at the same interval of time. Inset: D Fluorescence intensity 
at 527 nm as a function of concentration of monensin added] 
 
   
  (a)  (b) 
 
Fig. 4: (a) A typical AO uptake by three cell lines: (1) K562, (2) K562/adr and (3) K562/10000 cells, (b) intralysosmal 
concentration (Cv) of AO in (□) K562, (■) K562/adr and (▲) K562/10000 cell lines as a function  of  total 
concentration  (CT)  of AO added [Cells were incubated in 1 cm quartz cuvette containing 3.5 mL HEPES-Na
+ 
buffer at 37°C and vigorously stirred. After the addition of AO, the fluorescence intensity detected at 527 nm 
(excitation wavelength 491 nm) was F0 and decreased progressively until the system reached a steady state (FT). 
Then 3.5´10
6 cells were added yielding a progressive decrease in fluorescence intensity at 527 nm which 
corresponded to amounts of AO passively diffused through plasma membrane. After the system reached a new 
steady state (Fc), the pH gradient was eliminated by 3 mM monensin resulting in an increased in fluorescence 
intensity, after which and then a new steady state was reached and characterized by the fluorescence intensity 
value  Fmon.  This  corresponded  to  liberation  of  the  lysosomal  AO  (Cv)  to  cytoplasm  and  extra  cellular 
compartments. The lysosomal (Cv) and the initial rate of uptake ( i V
+ ) of AO can be determined using the 
following equation  ( ) mon c
v T
T
F F
C C
F
 -    = ´ 
   
 and  i
t Cell
dF
V
dt
+
=
  =  
 
, repectively] 
 
At the steady state cells were taken and injected into 
flow  cytometer  to  analyze  the  ratio  of  red  to  green 
fluorescence (Fig. 2). The Cv was evaluated by successive 
addition  of  incremental  monensin concentration (up to 
6  µM)  into  cells,  yielding  an  increase  in  fluorescence 
intensity of AO which corresponded to the amount of Am. J. Applied Sci., 6 (9): 1637-1646, 2009 
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AO  released  from  lysosomes  to  cytoplasm.  D 
Fluorescence  intensity  i.e.,  the  difference  of  AO 
fluorescence  intensity  before  and  after  addition  of 
monensin,  corresponding  to  the  Cv,  as  a  function  of 
concentration of monensin added is shown in the inset 
of Fig. 3. The maximal Cv was determined on addition 
of 3 mM monensin.  
  The representative kinetics of AO uptake in K562, 
K562/adr and K562/10000 clls are shown in Fig. 4a. 
The initial rate of uptake (V
+
i) was determined in all 
cell lines used and was proportional to CT added. This 
suggested that in the concentration range used, AO in 
neutral  form  passively  diffused  across  plasma 
membrane  into  cells.  The  mean  influx  coefficient  of 
AO (k+) was obtained by linear least-square fit of data 
of  the  three  cell  lines  and  was  103±34  pL.s
-1.cell
-1. 
The Cv was identical and reached a pseudo-plateau, when 
the concentration of added AO was above 1.75 mM in 
K562  and  K562/adr  cells.  However,  very  low 
quantities  of  AO  were  accumulated  in  K562/10000 
cells (Fig. 4b). 
 
Pgp-mediated efflux of pirarubicin and AO: In this 
study, we checked that in the range of concentrations 
of pirarubicin used, the accumulation in compartments 
other    than  the  nucleus  was  negligible.  Figure  5a 
shows  that  K562/adr  cells  contained  functional  Pgp 
(ka = 2.6±0.9 pL.s
-1.cell
-1) which extruded piraribicin 
out of cells about 2-fold lesser than K562/10000 cells 
(4.7±1.0  pL.s
-1.cell
-1).  It  should  be  noted  that  the 
kinetics  of  Pgp-mediated  efflux  of  AO  determined 
from K562/adr cells was very low and could not be 
determined  by  this  method.  However,  initial  rate  of 
active  efflux  of  AO  was  easily  measured  from 
K562/10000, as indicated in Fig. 5b. In this series of 
experiments,    saturation    of    initial    rate  of  active 
efflux  of  AO  was  not  obtained.  The  mean  rate 
constant  of  active  efflux  (kae)  of  AO  was  equal  to 
1,930±300 pL. s
-1.cell
-1. 
 
DISCUSSION 
 
  The results clearly showed for present study that 
AO was exclusively accumulated in acidic organelles, 
particularly  lysosomes,  although  the  nuclear 
compartment was reported as its potential intracellular 
target
[14-16].  In  fact,  efficacy  of  AO  improved 
significantly by 2 fold, when cells were incubated in 
the presence of 25 nM monensin. The results should 
be interpreted as an addition of monensin resulted in 
an  elimination  of  intracellular  DpH  formation  and 
consequently the release of AO from lysosomes to the 
cytosolic and nuclear compartment thus increased in 
its  efficacy.  The  results  suggested  that  for  AO,  the 
sequestration  of  the  molecule  in  lysosomes  play  a 
predominant  mechanism  of  MDR  phenomenon. 
However, for MDR cells even after elimination of pH 
gradient formation were still more resistant to AO than 
their corresponding parental K562 cells, indicating the 
Pgp-mediated  efflux  still  plays  role  on  the  MDR 
phenomenon.  The  different  observation  was  done  for 
pirarubicin  that  is  preferable  accumulated  on  nuclear 
compartment. Although the function of lysosomes was 
inhibited  in  the  presence  of  25  nM  monensin,  no 
additional  sensitivity  to  pirarubicin  was  found  for 
K562/adr and only slightly for K562/10000 cells. The 
results signified that the sequestration of pirarubicin in 
lysosomes  did  not  contribute  to  drug  resistance  for 
K562/adr  cells  with  lower  degree  of  resistance  and 
seemed  to  take  role  when  MDR  cells  became  higher 
resistance such as K562/10000 cells.  
  Earlier, we reported that the activity of anticancer 
drug depends on its concentration in the compartment, 
where  its  intracellular  target  is  located  and  this 
intracellular concentration of drug directly depends on 
the  mechanisms  of  its  transport  into  the  cells,  in 
particular, the kinetic parameters
[13]. Thus, the kinetic 
parameters of pirarubicin and AO for K562, K562/adr 
and K562/10000 cells were determined. Results showed 
that pirarubicin passively diffused through the plasma 
membrane  of  K562,  K562/adr  and  K562/10000  cells 
with  the  same  values  of  k+  =  3.4±0.3  pL.s
-1.cell
-1[7]. 
Similar  results  were  found  for  AO,  which  passively 
diffused through plasma membrane of these cell lines 
about 30-fold faster than pirarubicin. It should be noted 
that the ka cannot be able to measure for AO but easily 
done with pirarubicin for K562/adr cells. This should 
be interpreted that the k+ of AO is very fast, compared 
with  the  ka.  Under  these  conditions,  Pgp  should  be 
saturated  and  the  activity  of  Pgp  per  time  turnover 
could  not  maintain  the  gradient  between  extra-  and 
intracellular AO concentrations. We also showed that 
K562/10000  cells  contained  only  about  two-fold  of 
functional Pgp more than K562/adr cells as shown in 
Fig. 5a, but the mean rate of active efflux (kae) of AO 
was  1,930±300  pL.s
-1.cell
-1.  The  overall  results 
indicated  that  AO  is  a  poor  substrate  of  Pgp.  It  was 
possible that its mean rate of active efflux determined 
for K562/10000 cells could be contributed by not only 
Pgp but other mechanisms that can convey numerous 
molecules of AO from cytoplasm to the exterior of cells 
per  turn  should  be  involved.  This  was  probably  a 
characteristic  of  a  sequestration  of  AO  in  lysosomes 
following  an  enhanced  exocytosis.  The  result  was 
confirmed by the low Cv in K562/10000 cells.  Am. J. Applied Sci., 6 (9): 1637-1646, 2009 
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Fig. 5: Pgp-mediated  efflux  of  (a)  pirarubicin  and  (b) 
AO  determined  from  (■)  K562/adr  and  (▲) 
K562/10000  cells  plotted  as  a  function  of  free 
cytosolic concentration (Ci) of pirarubicin or AO 
added [Results were obtained from the series of 
experiments with the same conditions as Fig. 4. 
The  transport  of  THP  was  best  described  by 
Hill’s  equation  of  enzyme  kinetics, 
nH
max i
a nH nH
m i
V .C
V
K C
=
+
 where Km was 1.05±0.01 mM and 
Vmax
  was  2.6±0.9  nM.s
-1  for  K562/adr  and 
4.7±1.0  nM.s
-1,  respectively.  Hill’s  coefficient 
(nH)  was  near  to  1.95.  The  line  represents  the 
mean value from the triplicate data] 
 
  The  accumulation  of  AO  in  lysosomes  and 
cytoplasm  could  also  provide  information  about 
physico-chemical  properties  of  microenvironments, 
especially the local pH. The overall concentrations of 
AO in each compartment were measured in molar units 
(global conc.) for all series of experiments. The Ci and 
Cv allowed us to determine pHi and pHv as shown in Fig. 
6. The pHi for all cell lines used in these experiments was 
about  7.25  (Fig.  6a).  The  pHv  as  a  function  of  Cv  is 
indicated in Fig. 6b. In K562 and K562/adr cells, the pHv 
increased with Cv then reached a plateau when Cv was 
equal to 0.5 mM, where pHv about 7.2 closely to pHi. 
These results suggested that either the H
+-ATPase pump 
may  be  saturated  or  the  maximum  volume  of  these 
organelles  could  be  attained  when  there  was  enough 
concentration  of  the  basic  molecule  inside.  The  initial 
pHv  (without  AO  inside)  was  calculated  from  the 
function  of  ( ) V V pH C = ∫   using  a  non-linear  plot 
(Boltzman’s  model)  for  K562  and  K562/adr  cell  lines 
and was equal to 6.30. Similar results were obtained in 
K562/10000 cells but no saturation of pHv was obtained 
because of too low Cv; the data were linearly least-square 
fitted and the initial pHv value was about 5.70. Both an 
acidified of pHv and alkalinized of pHi of MDR cells 
compared  with  its  corresponding  drug-sensitive  cells 
were   also   reported  in  literatures
[5,17-21].  For   example, 
 
 
Fig. 6: Calculated intracellular (a) and intraluminal (b) 
pH of lysosomes of (□) K562, (■) K562/adr and 
(▲)  K562/10000  cell  lines  as  a  function  of 
concentration  of  AO  [data  from  series  of 
experiments of Fig. 4] 
 
DpH  was  found  to  be  1.2  and 0.3 unit in MDR 
(pHi = 7.1±0.025)   and   sensitive   MCF-7    cells 
(pHi  =  6.8±0.025)  respectively
[19].  In  addition, 
acidification  of  lysosome  was  also  reported  in  drug-
resistant cells
[5]. 
  The  application  of  AO,  an  intrinsic  fluorescent 
basic  molecule  as  molecular  probe,  allowed  us  to 
monitor  the  spontaneous  changes  in  pHi  during  AO 
incorporation into cells (Fig. 6a). Results suggested that 
uptake of AO stimulated acidification of pHi in MDR 
cells with high degree of resistance. It was important to 
note  that  AO  did  not  induce  any  pHi  change  in 
K562/adr  cell.  Recently,  we  reported  that  in 
K562/10000 cells, the K
+/H
+ antiporter exchanger could 
be  activated  by  pirarubicin  transport,  leading  to  an 
acidification of pHi
[7]. In fact, the maintenance of pHi 
within a narrow physiological range is vital to normal 
cell  function.  Nevertheless,  the  intracellular  free  H
+ 
could vary in response to different stimuli. Evidences 
indicated  that  intracellular  protons  could  serve  as  a 
second  messenger  in  regulating  multiple  cellular 
functions
[22,23]. 
 
CONCLUSION 
 
  The present study demonstrated that by using the 
same  cell  lines  and  methodology,  but  different 
molecular probes such as AO and pirarubicin, different 
predominant cellular defense processes were elucidated. 
The predominant mechanism of MDR phenomenon is 
depended totally on the nature of the molecular probe 
used.  In  fact,  the  role  of  Pgp-mediated  efflux  of 
cytotoxic drug out of the cell conferring lower available 
intracellular concentration, thereby lower efficiency can 
be  clearly  demonstrated  using  pirarubicin.  The  drug 
sequestration in lysosomes was also a major cause of Am. J. Applied Sci., 6 (9): 1637-1646, 2009 
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lowering  available  intracellular  concentration  of  the 
drug which provided the advantages for the MDR cells, 
particularly  K562/10000  cells,  to  survive  prolonged 
exposure to cytotoxic agents and thus to contribute to 
chemotherapeutic resistance. 
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